retatrutide clinical data retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide clinical trial weight loss

Our team can assist with prior authorizations if needed, and you can learn more about insurance for weight loss and preventive care

While semaglutide typically achieves 15-17% weight reduction in clinical studies, retatrutide powder demonstrates potential for 20-30% weight loss in substantial patient populations

While both drugs can lead to significant weight loss, its also important to remember that the extent of effectiveness can vary based on individual factors such as body mass index (BMI), existing health conditions and adherence to the treatment plan

Individuals who encounter websites or services offering retatrutide for sale outside of a clinical trial should exercise extreme caution such products are unlicensed, unregulated, and potentially dangerous

Clinicians should remain attentive to forthcoming trial data that may guide integration of GLP-1 and dual agonists into standard care

Whats not included: Coaching, dietitian access, nutrition programming, community support, or labs